Arax Advisory Partners’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $64.6K | Buy |
730
+38
| +5% | +$3.27K | ﹤0.01% | 1576 |
|
|
2025
Q4 | $54.3K | Buy |
692
+77
| +13% | +$5.86K | ﹤0.01% | 1566 |
|
|
2025
Q3 | $41.2K | Buy |
615
+103
| +20% | +$7.41K | ﹤0.01% | 1921 |
|
|
2025
Q2 | $48.2K | Sell |
512
-3
| -0.6% | -$329 | ﹤0.01% | 1254 |
|
|
2025
Q1 | $61.1K | Sell |
515
-6
| -1% | -$818 | ﹤0.01% | 881 |
|
|
2024
Q4 | $68.7K | Sell |
521
-7
| -1% | -$859 | ﹤0.01% | 801 |
|
|
2024
Q3 | $68.5K | Buy |
528
+1
| +0.2% | +$118 | 0.01% | 603 |
|
|
2024
Q2 | $45.7K | Buy |
527
+19
| +4% | +$1.99K | ﹤0.01% | 694 |
|
|
2024
Q1 | $55.7K | Buy |
508
+1
| +0.2% | +$101 | 0.01% | 474 |
|
|
2023
Q4 | $53.1K | Hold |
507
| – | – | 0.01% | 465 |
|
|
2023
Q3 | $53.2K | Buy |
507
+1
| +0.2% | +$128 | 0.01% | 457 |
|
|
2023
Q2 | $65K | Sell |
506
-53
| -9% | -$8.08K | 0.01% | 424 |
|
|
2023
Q1 | $97.6K | Buy |
559
+1
| +0.2% | +$179 | 0.01% | 350 |
|
|
2022
Q4 | $92.7K | Sell |
558
-278
| -33% | -$43.6K | 0.01% | 346 |
|
|
2022
Q3 | $118K | Hold |
836
| – | – | 0.02% | 288 |
|
|
2022
Q2 | $170K | Buy |
836
+1
| +0.1% | +$219 | 0.03% | 234 |
|
|
2022
Q1 | $213K | Buy |
835
+150
| +22% | +$40.7K | 0.03% | 237 |
|
|
2021
Q4 | $225K | Buy |
685
+332
| +94% | +$104K | 0.03% | 229 |
|
|
2021
Q3 | $107K | Hold |
353
| – | – | 0.01% | 316 |
|
|
2021
Q2 | $96K | Buy |
+353
| New | +$89.5K | 0.01% | 344 |
|
|
2020
Q4 | $101K | Hold |
353
| – | – | 0.01% | 298 |
|
|
2020
Q3 | $90K | Hold |
353
| – | – | 0.02% | 282 |
|
|
2020
Q2 | $77K | Hold |
353
| – | – | 0.01% | 292 |
|
|
2020
Q1 | $80K | Buy |
353
+118
| +50% | +$29.1K | 0.02% | 267 |
|
|
2019
Q4 | $59K | Buy |
+235
| New | +$55K | 0.02% | 316 |
|
Other funds holding MLAB
LPP
VCM
RIM
RA
